Expression and significance of PTEN and miR-92 in hepatocellular carcinoma

Molecular Medicine Reports

Volumn 7, Issue 5, 2013, Pages 1413-1416

  Zhao, Bin ^a   Zhu, Yueting ^b   Cui, Kai ^b   Gao, Jie ^b   Yu, Fachang ^b   Chen, Liang ^b   Li, Sheng ^b  

^a Key Laboratory of Cardiovascular Proteomics of Shandong Province   (China)

^b SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Hepatocellular cancer; MiR 92; Phosphatase and tensin homolog

Indexed keywords

BETA ACTIN; MICRORNA; MICRORNA 92; PEROXIDASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; STREPTAVIDIN; UNCLASSIFIED DRUG;

ARTICLE; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL;

CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MICRORNAS; PTEN PHOSPHOHYDROLASE; RNA, MESSENGER;

EID: 84875991695     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1406     Document Type: Article

References (20)

1. El-Serag HB and Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576, 2007.
2. El-Serag HB and Mason AC: Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340: 745-750, 1999.
3. Tamguney T and Stokoe D: New insights into PTEN. J Cell Sci 120: 4071-4079, 2007.
4. Martin J and Dufour JF: Tumor suppressor and hepatocellular carcinoma. World J Gastroenterol 14: 1720-1733, 2008.
5. Yao YJ, Ping XL, Zhang H, et al: PTEN/MMAC1 mutations in hepatocellular carcinomas. Oncogene 18: 3181-3185, 1999.
6. Steck PA, Pershouse MA, Jasser SA, et al: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: 356-362, 1997.
7. Lee Y, Kim M, Han J, et al: MicroRNA genes are transcribed by RNA polymerase II. EMBO J 23: 4051-4060, 2004.
8. Xie X, Lu J, Kulbokas EJ, et al: Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals. Nature 434: 338-345, 2005.
9. Mendell JT: miRiad roles for the miR-17-92 cluster in development and disease. Cell 133: 217-222, 2008.
10. Xiao C, Srinivasan L, Calado DP, et al: Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 9: 405-414, 2008.
11. Slipicevic A, Holm R, Nguyen MT, Bohler PJ, Davidson B and Florenes VA: Expression of activated Akt and PTEN in malignant melanomas: relationship with clinical outcome. Am J Clin Pathol 124: 528-536, 2005.
12. Kerr JF, Winterford CM and Harmon BV: Apoptosis. Its significance in cancer and cancer therapy. Cancer 73: 2013-2026, 1994.
13. Xu Z, Stokoe D, Kane LP and Weiss A: The inducible expression of the tumor suppressor gene PTEN promotes apoptosis and decreases cell size by inhibiting the PI3K/Akt pathway in Jurkat T cells. Cell Growth Differ 13: 285-296, 2002.
14. Smith JS and Jenkins RB: Genetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implications. Front Biosci 5: D213-D231, 2000.
15. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658, 2007.
16. Huang YS, Dai Y, Yu XF, et al: Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis. J Gastroenterol Hepatol 23: 87-94, 2008.
17. Huang GL, Zhang XH, Guo GL, et al: Expression of microRNA-21 in invasive ductal carcinoma of the breast and its association with phosphatase and tensin homolog deleted from chromosome expression and clinicopathologic features. Zhonghua Yi Xue Za Zhi 88: 2833-2837, 2008.
18. Fang J, Ding M, Yang L, Liu LZ and Jiang BH: PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis. Cell Signal 19: 2487-2497, 2007.
19. Mann CD, Neal CP, Garcea G, Manson MM, Dennison AR and Berry DP: Prognostic molecular markers in hepatocellular carcinoma: a systematic review. Eur J Cancer 43: 979-992, 2007.
20. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV and Mendell JT: c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839-843, 2005.